The drug, Imfinzi, works as a first-line treatment for extensive-stage small-cell lung cancer and will be in direct competition with Roche's Tecentriq, in today's bite-sized hospital and health industry news from Maryland, New York, and Washington.
U.S. officials on Tuesday reported more than 850 additional deaths tied to COVID-19—and projected the new coronavirus could kill between 100,000 and 240,000 Americans overall. See which states are reporting the highest numbers of COVID-19 cases and deaths on our interactive maps.
EvergreenHealth unexpectedly became the first U.S. acute care hospital with COVID-19 patients and has been at the forefront of early learnings ever since. Mary Shepler, CNO at EvergreenHealth, spoke with Advisory Board's Carol Boston-Fleischhauer about the hospital’s early experiences and key advice she would give to health care executives that are bracing for a COVID-19 surge.
Rachel Martin, 39, didn't realize the toll her drinking was taking on her health until she was diagnosed with acute liver disease in 2019—and experts say cases like Martin's are becoming increasingly common in the United States, Sahri Rudavsky writes for USA Today.
In New York, nursing homes can no longer deny admission to patients who have or are suspected to have COVID-19—and other states are likely to follow suit as the hospitals reach peak capacity. Advisory Board's Carolyn Buys outlines steps nursing homes and hospitals can take now to prepare for the influx.
Print All Daily Briefing Article from
Have a Question?
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.